封面
市场调查报告书
商品编码
1747309

非处方抗真菌药物市场:按产品类型、活性成分、应用、使用者、分销管道和地区划分

OTC Topical Antifungals Market, By Product Type, By Active Ingredient, By Application, By User, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球非处方抗真菌药物市场规模估计为 32.8 亿美元,预计到 2032 年将达到 49 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 5.9%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 32.8亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 5.90% 2032年价值预测 49亿美元

近年来,由于真菌感染疾病的日益流行和非处方药需求的不断增长,全球 OTC 外用抗真菌药物市场出现了显着增长。外用抗真菌药物物是直接涂抹在皮肤、指甲和头髮上,用于治疗各种真菌感染疾病(如足癣、癣和念珠菌症)的药物。市场提供各种各样的产品,如乳膏、软膏、喷雾剂和粉剂,这些产品无需处方笺即可轻鬆取得。这些产品的便利性和可用性使其在寻求快速有效缓解真菌感染疾病的消费者中广受欢迎。随着个人卫生和自我护理意识的不断增强,全球 OTC 外用抗真菌药物市场预计将进一步扩大,为製造商和零售商提供有利可图的机会。

市场动态

全球非处方抗真菌药物市场受到多种关键因素的影响,这些因素推动了其成长,带来了挑战,也提供了机会。主要驱动因素之一是全球真菌感染疾病的增加,尤其是在热带气候和卫生条件差的新兴国家。此外,糖尿病盛行率的上升使人们更容易受到真菌感染疾病,这也促进了市场的成长。此外,人们对个人卫生和及时治疗真菌感染疾病重要性的认识不断提高,也导致对非处方外用抗真菌药物的需求增加。然而,市场上也存在一些限制因素,例如处方药和家庭疗法等替代治疗方案的可用性,这可能会限制市场的成长潜力。此外,一些外用抗真菌药物会引起皮肤刺激和过敏反应等副作用,这可能会导致一些消费者不愿意使用这些产品。儘管存在这些挑战,但对于那些开发创新和有针对性的配方以满足特定消费者需求和偏好的製造商来说,市场代表着一个巨大的商机。对天然和有机抗真菌产品的需求不断增长以及向新兴市场扩张的潜力为全球非处方抗真菌药物市场提供了有希望的成长途径。

本研究的主要特点

  • 本报告对全球非处方抗真菌药物市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数,对全球非处方抗真菌药物市场的主要企业进行了概述。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
  • 全球非处方外用抗真菌剂市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过分析全球非处方抗真菌药物市场所使用的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020 年至 2032 年全球 OTC 外用抗真菌药物市场(依产品类型)

  • 奶油
  • 软膏
  • 粉末
  • 凝胶
  • 洗剂

5. 2020 年至 2032 年全球 OTC 外用抗真菌药物市场(按活性成分划分)

  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • 托萘酯
  • 其他的

6. 2020 年至 2032 年全球 OTC 外用抗真菌药物市场(依应用)

  • 皮癣菌病菌感染
  • 酵母菌感染疾病
  • 指甲感染疾病
  • 足癣

7. 2020 年至 2032 年全球 OTC 外用抗真菌药物市场(依使用者划分)

  • 成人
  • 孩子们
  • 老年人

8. 2020 年至 2032 年全球 OTC 外用抗真菌药物市场(依分销管道)

  • 网路药局
  • 零售药局
  • 超级市场/大卖场
  • 专卖店

9. 2020 年至 2032 年全球非处方抗真菌药物市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十章 竞争格局

  • Johnson & Johnson
  • Bayer AG
  • GlaxoSmithKline
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Sanofi SA
  • Astellas Pharma Inc.
  • Mylan NV
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International
  • Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd.

第 11 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十二章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7970

Global OTC Topical Antifungals Market is estimated to be valued at USD 3.28 Bn in 2025 and is expected to reach USD 4.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.28 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.90% 2032 Value Projection: USD 4.90 Bn

The global OTC topical antifungals market has witnessed significant growth in recent years, driven by the increasing prevalence of fungal infections and the rising demand for over-the-counter remedies. Topical antifungals are medications applied directly to the skin, nails, or hair to treat various fungal infections, such as athlete's foot, ringworm, and candidiasis. The market encompasses a wide range of products, including creams, ointments, sprays, and powders, which are readily available without a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers seeking quick and effective relief from fungal infections. As awareness about personal hygiene and self-care continues to grow, the global OTC topical antifungals market is expected to expand further, offering lucrative opportunities for manufacturers and retailers alike.

Market Dynamics

The global OTC topical antifungals market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing prevalence of fungal infections worldwide, particularly in developing countries with tropical climates and poor hygiene conditions. The rising incidence of diabetes, which makes individuals more susceptible to fungal infections, also contributes to the market's growth. Additionally, the growing awareness about personal hygiene and the importance of prompt treatment for fungal infections has led to a higher demand for OTC topical antifungals. However, the market faces certain restraints, such as the availability of alternative treatment options, including prescription medications and home remedies, which may limit its growth potential. Moreover, the side effects associated with some topical antifungals, such as skin irritation and allergic reactions, may deter some consumers from using these products. Despite these challenges, the market presents significant opportunities for manufacturers to develop innovative and targeted formulations that address specific consumer needs and preferences. The increasing demand for natural and organic antifungal products, as well as the potential for expansion into emerging markets, offers promising avenues for growth in the global OTC topical antifungals market.

Key Features of the Study

  • This report provides in-depth analysis of the global OTC topical antifungals market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global OTC topical antifungals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi S.A., Astellas Pharma Inc., Mylan N.V., Amgen Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global OTC topical antifungals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global OTC topical antifungals market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Creams
    • Ointments
    • Sprays
    • Powders
    • Gels
    • Lotions
  • Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
    • Clotrimazole
    • Miconazole
    • Terbinafine
    • Ketoconazole
    • Tolnaftate
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dermatophyte Infections
    • Yeast Infections
    • Nail Infections
    • Ringworm
    • Athlete's Foot
  • User Insights (Revenue, USD Bn, 2020 - 2032)
    • Adults
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online Pharmacies
    • Retail Pharmacies
    • Supermarkets/Hypermarkets
    • Specialty Stores
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Bayer AG
    • GlaxoSmithKline
    • Pfizer Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Sanofi S.A.
    • Astellas Pharma Inc.
    • Mylan N.V.
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals International
    • Reddy's Laboratories
    • Sun Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global OTC Topical Antifungals Market, By Product Type
    • Global OTC Topical Antifungals Market, By Active Ingredient
    • Global OTC Topical Antifungals Market, By Application
    • Global OTC Topical Antifungals Market, By User
    • Global OTC Topical Antifungals Market, By Distribution Channel
    • Global OTC Topical Antifungals Market, By Region

3. Market Dynamics, Regulations,and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global OTC Topical Antifungals Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lotions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global OTC Topical Antifungals Market, By Active Ingredient, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clotrimazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Miconazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Terbinafine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ketoconazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tolnaftate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global OTC Topical Antifungals Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dermatophyte Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Yeast Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nail Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ringworm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Athlete's Foot
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global OTC Topical Antifungals Market, By User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global OTC Topical Antifungals Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Supermarkets/Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global OTC Topical Antifungals Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Valeant Pharmaceuticals International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us